Consolidated Statement Of Cash Flows

Delta-Fly Pharma, Inc. - Filing #7296920

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,064,391,000 JPY
-616,554,000 JPY
Net cash provided by (used in) operating activities
-1,066,826,000 JPY
-619,048,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
JPY
-421,000 JPY
Net cash provided by (used in) investing activities
JPY
918,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
JPY
211,138,000 JPY
Effect of exchange rate change on cash and cash equivalents
-1,112,000 JPY
-538,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,067,939,000 JPY
-407,529,000 JPY
Cash and cash equivalents
349,122,000 JPY
1,417,062,000 JPY
436,811,000 JPY
844,341,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.